FDA targets illegal ephedra marketing with Yellow Jackets
FDA stops imports of Yellow Jackets an ephedra based herbal pill and emails a Dutch operator to halt marketing as a substitute for cocaine and other drugs. The issue ties to a Senate hearing on ephedra safety as a teenager’s death prompts testimony and a broader probe into possible safety misrepresentations by a U.S. manufacturer. Also Senatorial confirmation hearings proceed for FDA nominee Dr Mark McClellan despite questions over agency controversies.